title: Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.
authors.forename: R K
authors.initials: RK
authors.lastname: Moitra
authors.forename: J M
authors.initials: JM
authors.lastname: Ledingham
authors.forename: R G
authors.initials: RG
authors.lastname: Hull
authors.forename: F C
authors.initials: FC
authors.lastname: McCrae
authors.forename: A L
authors.initials: AL
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Shaban
authors.forename: K R
authors.initials: KR
authors.lastname: Mackay
mesh_terms: D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D007263:Infusions, Parenteral; D008727:Methotrexate / Q000008:administration & dosage*; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate